Update on Preeclampsia and Hypertensive Disorders of Pregnancy

• A. Rosenberg. Emily ^[1] ; W. Seely, Ellen ^[2]
  1. [1] Medical University of South Carolina

     Medical University of South Carolina

     Estados Unidos

     
  2. [2] Harvard Medical School

     Harvard Medical School

     City of Boston, Estados Unidos

     
• Localización: Endocrinology and metabolism clinics of North America, ISSN 0889-8529, Vol. 53, Nº. 2, 2024, págs. 377-389
• Idioma: inglés
• Enlaces
  • Texto completo
• Resumen

  • There have been recent advances in the prevention, diagnosis, and management of hypertensive disorders of pregnancy which complicate approximately 16% of pregnancies in the United States. Initiation of low-dose aspirin by 16 weeks’ gestation reduces preeclampsia in high-risk women.The Food and Drug Administration approved the use of the soluble fms-like tyrosine kinase 1/placental growth factor ratio for the short-term prediction of preeclampsia. Pregnancy outcomes are improved in women with chronic hypertension when antihypertensives are initiated at a threshold blood pressure of 140/90 mm Hg. Women with prior preeclampsia have increased cardiovascular disease risk and should receive risk reduction counseling